(Q33928699)

30 July 2017

1 reference

title

Once-daily dosing of aminoglycoside antibiotics (English)

1 reference

30 July 2017

0 references

Fisman DN

1

1 reference

PubMed ID

10829267

30 July 2017

Kaye KM

series ordinal

2

1 reference

30 July 2017

1 June 2000

1 reference

Infectious Disease Clinics of North America

30 July 2017

1 reference

30 July 2017

14

1 reference

30 July 2017

2

1 reference

30 July 2017

475-487

1 reference

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Adaptive resistance following single doses of gentamicin in a dynamic in vitro model.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

The Influence of Dosage Regimen on Experimental Gentamicin Nephrotoxicity: Dissociation of Peak Serum Levels from Renal Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Monitoring serum concentrations for once-daily netilmicin dosing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia i

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

The postantibiotic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Aminoglycoside pharmacokinetics: volume of distribution in specific adult patient subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

1 reference

7 January 2021

Gentamicin once-daily versus thrice-daily in children

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

From the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Practicalities of once-daily aminoglycoside dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

In vivo postantibiotic effect in a thigh infection in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970259-2

7 January 2021

10.1016/S0891-5520(05)70259-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10829267